Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Protect Against Cisplatin-Induced Ovarian Granulosa Cell Stress and Apoptosis in Vitro

Liping Sun,Dong Li,Kun Song,Jianlu Wei,Shu Yao,Zhao Li,Xuantao Su,Xiuli Ju,Lan Chao,Xiaohui Deng,Beihua Kong,Li
DOI: https://doi.org/10.1038/s41598-017-02786-x
IF: 4.6
2017-01-01
Scientific Reports
Abstract:Human umbilical cord mesenchymal stem cells (huMSCs) can treat primary ovarian insufficiency (POI) related to ovarian granulosa cell (OGC) apoptosis caused by cisplatin chemotherapy. Exosomes are a class of membranous vesicles with diameters of 30-200 nm that are constitutively released by eukaryotic cells. Exosomes mediate local cell-to-cell communication by transferring microRNAs and proteins. In the present study, we demonstrated the effects of exosomes derived from huMSCs (huMSC-EXOs) on a cisplatin-induced OGC model in vitro and discussed the preliminary mechanisms involved in these effects. We successfully extracted huMSC-EXOs from huMSC culture supernatant and observed the effective uptake of exosomes by cells with fluorescent staining. Using flow cytometry (with annexin-V/PI labelling), we found that huMSC-EXOs increased the number of living cells. Western blotting showed that the expression of Bcl-2 and caspase-3 were upregulated, whilst the expression of Bax, cleaved caspase-3 and cleaved PARP were downregulated to protect OGCs. These results suggest that huMSC-EXOs can be used to prevent and treat chemotherapy-induced OGC apoptosis in vitro. Therefore, this work provides insight and further evidence of stem cell function and indicates that huMSC-EXOs protect OGCs from cisplatin-induced injury in vitro.
What problem does this paper attempt to address?